RXST — RxSight, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1111485 ·
Last close
$5.99
Market Cap
$247.97M
52W High
$8.08
52W Low
$5.30
ADV30
690,791
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 30,893,000 | 23,498,000 | -17,829,000 | -15,884,000 | 303,993,000 | 17,573,000 | 36,698,000 |
| Dec 2025 | 32,608,000 | 25,263,000 | -11,337,000 | -9,152,000 | 311,814,000 | 19,949,000 | 36,131,000 |
| Sep 2025 | 30,340,000 | 24,227,000 | -12,178,000 | -9,816,000 | 308,533,000 | 29,633,000 | 32,563,000 |
| Jun 2025 | 33,637,000 | 25,190,000 | -14,003,000 | -11,786,000 | 309,009,000 | 40,355,000 | 30,997,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,511,000
Investing CF
$16,889,000
Financing CF
$1,863,000
CapEx
$-3,830,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.95
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-661,039,000
Inventory
$31,559,000
Receivables
$23,383,000
ST Investments
$208,179,000
EBIT TTM
$-38,859,000
Pretax Income TTM
$-38,879,000
Interest Exp TTM
$20,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$127,477,000
EBITDA
$-52,022,000
Free Cash Flow
$-969,250
Enterprise Value
$40,911,688
Total Cash
$217,880,000
Total Debt
$10,826,000
Shares Out
41,396,609
Trailing EPS
$-1.13
Book Value
$6.68
ROE
-17.1%
ROA
-11.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 134,479,000 | -48,191,000 | -38,944,000 | 311,814,000 | 36,131,000 | — | -15,511,000 |
| Dec 2024 | 139,927,000 | -36,858,000 | -27,455,000 | 318,563,000 | 37,325,000 | — | -16,946,000 |
| Dec 2023 | 89,077,000 | -50,085,000 | -48,608,000 | 182,550,000 | 22,188,000 | — | -41,593,000 |
| Dec 2022 | 49,005,000 | -63,318,000 | -66,756,000 | 150,164,000 | 60,262,000 | — | -58,850,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.56
News headlines (Yahoo Finance, 1h cache)
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
2026-05-19 20:10 · Yahoo
RxSight (RXST) Q1 2026 Earnings Transcript
2026-05-12 16:04 · Yahoo
RxSight, Inc. Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo
RxSight Q1 Earnings Call Highlights
2026-05-07 05:12 · Yahoo
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
2026-05-06 22:30 · Yahoo
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
2026-05-06 20:05 · Yahoo
How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets
2026-05-04 04:31 · Yahoo
RxSight, Inc. to Present at the Bank of America Healthcare Conference
2026-04-29 20:10 · Yahoo
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
2026-04-22 20:10 · Yahoo
How The RxSight (RXST) Story Is Shifting With New Guidance And Street Price Targets
2026-04-19 08:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.